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INTRODUCTION
Chronic lymphocytic inflammation with pontine perivas-
cular enhancement responsive to steroids (CLIPPERS) is 
a rare CNS inflammatory disorder affecting prominently 
the brainstem and particularly the pons and adjacent areas 
such as the cerebellum [1]. It was shown that two main 
peculiar properties are essential to characterize the case 
as CLIPPERS; one of them is the classic MRI findings 
of post-gadolinium enhancing punctate and curvilinear 
lesions “peppering” in these areas with appropriate clin-
ical manifestation. The second requirement for a correct 
diagnosis is a dramatic clinical and radiological response 
to glucocorticosteroid (GCS) based immunosuppression. 
So, the diagnosis of CLIPPERS is based on clinical pre-
sentation, radiographic findings, response to steroids, and 
exclusion of other diagnoses with imaging, serum and CSF 
laboratory testing [2]. 
Although the underlying pathogenesis of this condition 
is poorly understood and the neuropathological findings 
are far from specific, there is reason to believe that this 
pathology has characteristic signs of an immune-mediated 
inflammatory disorder with a pronounced vascular and 
perivascular tropism predominantly located in the pons 
and the peripontine region [3]. However, the ultra-high-
field MRI at 7.0T revealed perivascular inflammation 
not only in the brainstem and cerebellum but also in 
brain areas with normal imaging on 3.0T MRI [4]. The 
immune-based nature of CLIPPERS has recently been 
confirmed. It was determined, CD45+ lymphocytes with 
a predominance of CD3+ T cells and CD4+ T cells were 
accumulated in vessel walls and perivascular area of brain-
stem and cerebellum of patients with CLIPPERS. CD4+ 
T cells also infiltrated the brainstem parenchyma. The 
presence of CD8+ T cells was less pronounced and only 
a few CD20+ B cells were observed [4]. The omics-based 
approach showed importance of cell adhesion molecules 
(VCAM-1, ICAM-1) and interleukins (IFN-γ, TNF-β, 
IL-1, IL-6, IL-10) upregulation, and IgG deposition in the 
pathogenesis of CLIPPERS but the central role, certainly, 
belongs to complement activation [4].  This allows them 
to be considered potential targets for the treatment of 
CLIPPERS. The monoclonal antibodies are very promising 
in this regard and first positive results already published 
[5]. It’s tocilizumab – IL-6 receptor-blocker provides the 
long-standing relapse-free time period even in the patients 
with various relapses and nonresponse to multiple agents. 
Immunosuppressive effects of tocilizumab are thought to 
be a result of the induction and expansion of B-regulatory 
cells as well as the differentiation of T cells into effector or 
regulatory T cells with a significant increase of regulatory 
T cells [5]. In addition, upregulated VCAM-1, ICAM-1, 
IL-8, and eotaxin in the CSF may be potential biomarkers 
in CLIPPERS.
In this case report, we demonstrate that early recognition 
of this syndrome and a directed diagnostic approach make 
treatment more effective, patient outcomes earlier, and 
limit or avoid unwanted complications.
CASE STUDY
A 40-year-old male admitted to the Center of Infectious 
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A RARE BRAINSTEM INFLAMMATORY SYNDROME, CLIPPERS, 
MYTH OR FACT. CASE REPORT WITH CRITICAL REVIEW
10.36740/WLek202101131 
 
Pavel A. Dyachenko1, Raisa A. Hramova2, Anatoly G. Dyachenko2
1 CЕNTЕR OF INFECTIOUS DISORDERS OF THE NERVOUS SYSTEM, SI “L.V. GROMASHEVSKY INSTITUTE OF EPIDEMIOLOGY AND INFECTION DISEASES  
OF NAMS OF UKRAINE”, KYIV, UKRAINE
2SUMY STATE UNIVERSITY, SUMY, UKRAINE
ABSTRACT
A very rare inflammatory disease of CNS, CLIPPERS syndrome, was recently described and only a few sporadic cases are reported in the medical literature. Its etiology and 
pathogenesis are unknown, that together with the polymorphic and sometimes confounding neurological manifestations, and radiological findings represent a real diagnostic 
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with complaints of sustained dizziness, vertigo, unsteady 
gait, blurred vision, weakness, fatigue, and decreased 
performance for more than a month. He has no relevant 
medical or family history. General clinical examination was 
normal. Clinical neurologic examination showed diplopia 
when looking to the left, left-sided facial hypoesthesia, 
slight deviation of the tongue to the left, light tremor of 
the hands at complicated Bare-probe. Nery, Stryumpel, 
Sharapov, and Chaddok symptoms were positive on one 
or both sides. Meningeal symptoms were not detected. He 
performed the coordination tests with intent, staggering 
in the Romberg pose.
A lumbar puncture was performed just on admission and 
CSF analysis revealed lymphocytic pleocytosis of 16 cell/µl 
(lymphocytes) with normal protein and glucose. Viral se-
rology for HSV1/2, CMV, EBV, VZV, mumps, adenovirus, 
and enterovirus was negative.  CSF PCR was reported to 
be negative for DNA of herpesviruses, M.tuberculosis, and 
Tox. Gondii. The oligoclonal band also was not revealed. 
MR imaging showed a site of the small infratentorial le-
sions of an inflammatory nature in the pons with spreading 
to the upper and lower cerebellar peduncles without clear 
contours, a region of an amplified at T2 W1 and weakened 
at T1 W1 signal has a total size of 22x47x28 mm, at the 
post-gadolinium scans, heterogeneous accumulation of 
contrast in the structure of the indicated region is preserved 
(Figure 1 and Figure 2).
The patient did not have a brainstem biopsy for neu-
ropathological diagnosis but met the clinical and MRI 
criteria of CLIPPERS as proposed by Tobin et al. [6], and 
an extensive workup did not yield an alternative diagnosis. 
Oral steroid treatment was started with 12 mg of methyl-
prednisolone per day i/v, tapered to 4 mg of methylpred-
nisolone per day during a month, and accompanied with 
a variety of steroid-sparing agents. We observed marked 
improvement of the clinical symptoms and partial resolu-
tion of MRI lesions after the use of methylprednisolone. 
DISCUSSION
CLIPPERS Syndrome is chronic inflammation with a 
disorder of the pons, MR imaging of the contrast en-
hancement of the perivascular spaces in the pons, which 
responsive to steroids. The disease is extremely rare, its 
etiology and pathogenesis remain unknown. Although a 
full set of diagnostic criteria has not yet been determined 
MRI finding showing punctate enhancement in a “pep-
per-like appearance” centred on the pons is regarded as 
the hallmark of CLIPPERS [1, 6]. However, new data show 
involvement in the inflammatory process of remote areas 
of the brain and spinal cord, which reduces the diagnostic 
value of neuroimaging findings [4]. Besides, such clinical 
and neuroimaging findings can occur at other pathologies 
and therefore cannot be considered quite specific [7, 8]. 
The diagnostic value of the second important criterion, 
response to steroids, seems even more controversial. In-
deed, almost all diseases with a pronounced inflammatory 
component respond to immunosuppressive drugs, includ-
ing steroids. Not surprising, corticosteroid therapy was 
typically associated with the disappearance of neurologic 
symptoms and regression of post gadolinium contrast 
enhancement [6]. So, successful steroid therapy is the 
crucial criterion to confirm ex juvantibus  the diagnosis 
of  CLIPPERS. However, the clinical effect of steroids 
is usually temporary and rare radical. Disease progres-
sion is accompanied by a reduction in remissions and a 
weakening effect. The final component of the differential 
diagnostic scheme, the absence of other alternative causes, 
Fig. 1. MR images at the post-gadolinium scans, heterogeneous accumulation of contrast in the structure of the indicated region is preserved.
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seems to be the most important. Indeed, some patients 
initially diagnosed with CLIPPERS syndrome because of 
the characteristic clinical and radiological symptoms later 
turned out to be an atypical presentation of malignant 
lymphoma and other inflammatory and no inflammatory 
disorders [2, 9]. So, the exclusion of other possible causes 
of the identified abnormalities is a necessary condition 
for a correct diagnosis.
CONCLUSIONS
CLIPPERS syndrome appears to be a mysterious and un-
common variant of encephalitis involving inflammation of 
the brain parenchyma and vasculitis, which represent a real 
diagnostic challenge for health practitioners. Despite the 
efforts to clarify its pathogenesis, CLIPPERS syndrome re-
mains a controversial nosological entity. It is thus necessary 
to evoke the diagnosis in front of any encephalitis etiologic 
Fig. 2. MR images of an inflammatory nature disorders in the pons with spreading to the upper and lower cerebellar peduncles without clear contours, 
a region of an amplified at T2 W1 signal has a total size of 22x47x28 mm.
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reason of which does not prove, particularly if recurrent 
and in elderly. Early diagnosis and adequate management 
can improve the prognosis of this disease. However, the 
low specificity and ambiguity of the proposed diagnostic 
symptoms do not allow to confidently differentiate CLIP-
PERS, which makes the search for new diagnostic tools 
and symptoms highly relevant. 
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